baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Oxurion NV/ BE0974487192 /

6/13/2025 2:42:31 PM	Chg. -0.0026	Volume	Bid2:59:36 PM	Ask5:40:00 PM	High	Low
0.0418EUR	-5.86%	107,078 Turnover: 4,391.7566	0.0406Bid Size: 4,000	0.0446Ask Size: 52,702	0.0446	0.0408

GlobeNewswire 7/25/2024 Oxurion Share Consolidation

GlobeNewswire 7/24/2024 Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024

GlobeNewswire 7/19/2024 Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atla...

GlobeNewswire 7/18/2024 Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

GlobeNewswire 7/11/2024 Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to b...

GlobeNewswire 7/8/2024 Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pio...

GlobeNewswire 7/4/2024 Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and con...

GlobeNewswire 6/7/2024 Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

GlobeNewswire 6/4/2024 Oxurion Announces Extraordinary General Shareholders’ Meeting

GlobeNewswire 5/27/2024 Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

GlobeNewswire 5/23/2024 Oxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024

GlobeNewswire 5/23/2024 Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atla...

GlobeNewswire 5/16/2024 Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

GlobeNewswire 5/14/2024 Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atla...

GlobeNewswire 5/13/2024 Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

GlobeNewswire 5/6/2024 Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD

GlobeNewswire 4/25/2024 Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

GlobeNewswire 4/15/2024 Publication Annual Report – Annual Shareholders' Meeting

GlobeNewswire 4/15/2024 Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessi...

GlobeNewswire 4/11/2024 Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC

GlobeNewswire 4/10/2024 Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program : Eleventh tranche fully ...

GlobeNewswire 4/5/2024 Postponement Annual Shareholders Meeting - Amendment financial calendar

GlobeNewswire 3/28/2024 Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

GlobeNewswire 3/27/2024 Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atl...

GlobeNewswire 3/26/2024 Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atl...

Oxurion NV/ BE0974487192 /

If you wish to receive reply to your feedback, please provide your email address.